[Pe-021] 一般演題ポスターセッション（英語）021

[Pe-021-4] The design of CIELO: A phase 3 trial of satralizumab in patients with autoimmune encephalitis (AE)

中嶋 秀人¹, Abboud Hesham², Irani Sarosh R.³, Lee Soon-tae⁴, Piquet Amanda⁵, Pittock Sean J.⁶, Yeh Ann E.⁷, Overell James⁸, Rajan Sharmila⁹, El-Khairi Muna¹⁰, Gelfand Jeffrey M.¹¹ (1.日本大学医学部 内科学系神経内科学分野, 2.UH Cleveland Medical Center, 3.NDCN, Oxford University, 4.Seoul National University Hospital, 5.University of Colorado, 6.Mayo Clinic, 7.SickKids, University of Toronto, 8.F. Hoffmann-La Roche Ltd., 9.Genentech, Inc., 10.Roche Products Ltd., 11.UCSF)